FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120814732> ?p ?o ?g. }

• W3120814732 abstract "The paper presents the results of research on the role of neuronal growth factors in the development and progression of cognitive and psychoemotional disorders. Peculiarities of Bacopa Monier and Ginkgo Biloba influence on structural and functional changes of the brain in the experiment and in certain groups of patients are shown. The results of treatment with phytocomplex (FC) Memostim® (fixed combination of Bacopa Monier - 150 mg and Ginkgo Biloba - 120 mg) of 30 patients with DE II grade due to atherosclerosis and hypertension are described. The control group consisted of 30 patients with grade II DE who were not prescribed FC Memostim®. After 3 months of treatment with FC Memostim®, a decrease in the frequency and severity of cephalic, vestibulo-atactic and asthenic syndromes was observed in patients. There was a significant improvement in cognitive functions (on the MoSA scale) and psycho-emotional state of patients. There was a significant improvement in the calculated operations and attention (by 22% relative to baseline, p <0.05) and the overall score on the test (+ 8%, p> 0.05). The general tendency to improve visual-constructive functions, memory, speech, executive functions, abstract thinking and orientation has been identified. Similar results of the effect of FC Memostim® on cognitive functions were obtained from the FAB questionnaire. According to the results of the survey of patients on the scale of quality of life, a significant positive dynamics of the integrative index (statistically significant increase by 31%), index of psychological well-being (increase by 32%), self-satisfaction (by 28%), indicators of physical well-being (by 18%) after 3 months of treatment with FC Memostim®. The level of neuronal growth factor (β-NGF) increased statistically significantly (by 67%). The analysis of the obtained data testifies to the effectiveness and safety of FC Memostim® in the treatment of patients with DE. Thus, the obtained data demonstrate the profound effect of FC Memostim® on the symptoms of cognitive and psychoemotional disorders in patients with DE, which is associated with an increase in NGF levels on the background of the course." @default.
• W3120814732 created "2021-01-18" @default.
• W3120814732 date "2020-01-01" @default.
• W3120814732 modified "2023-10-18" @default.
• W3120814732 title "New opportunities in treatment of patients with discirculatory encephalopathy: emphasis on nervous growth factor" @default.
• W3120814732 cites W1481880911 @default.
• W3120814732 cites W1999854171 @default.
• W3120814732 cites W2007230798 @default.
• W3120814732 cites W2021582729 @default.
• W3120814732 cites W2034370779 @default.
• W3120814732 cites W2050203286 @default.
• W3120814732 cites W2056092011 @default.
• W3120814732 cites W2080433636 @default.
• W3120814732 cites W2106620733 @default.
• W3120814732 cites W2145019170 @default.
• W3120814732 cites W2152415998 @default.
• W3120814732 cites W2164760065 @default.
• W3120814732 cites W2213958444 @default.
• W3120814732 cites W2508387736 @default.
• W3120814732 cites W2511321784 @default.
• W3120814732 cites W2612799687 @default.
• W3120814732 cites W2917880019 @default.
• W3120814732 cites W2992704481 @default.
• W3120814732 doi "https://doi.org/10.26565/2312-5675-2020-13-11" @default.
• W3120814732 hasPublicationYear "2020" @default.
• W3120814732 type Work @default.
• W3120814732 sameAs 3120814732 @default.
• W3120814732 citedByCount "1" @default.
• W3120814732 countsByYear W31208147322023 @default.
• W3120814732 crossrefType "journal-article" @default.
• W3120814732 hasBestOaLocation W31208147321 @default.
• W3120814732 hasConcept C118552586 @default.
• W3120814732 hasConcept C126322002 @default.
• W3120814732 hasConcept C15744967 @default.
• W3120814732 hasConcept C169900460 @default.
• W3120814732 hasConcept C2775968953 @default.
• W3120814732 hasConcept C2778998842 @default.
• W3120814732 hasConcept C2779951463 @default.
• W3120814732 hasConcept C542102704 @default.
• W3120814732 hasConcept C70410870 @default.
• W3120814732 hasConcept C71924100 @default.
• W3120814732 hasConcept C98274493 @default.
• W3120814732 hasConceptScore W3120814732C118552586 @default.
• W3120814732 hasConceptScore W3120814732C126322002 @default.
• W3120814732 hasConceptScore W3120814732C15744967 @default.
• W3120814732 hasConceptScore W3120814732C169900460 @default.
• W3120814732 hasConceptScore W3120814732C2775968953 @default.
• W3120814732 hasConceptScore W3120814732C2778998842 @default.
• W3120814732 hasConceptScore W3120814732C2779951463 @default.
• W3120814732 hasConceptScore W3120814732C542102704 @default.
• W3120814732 hasConceptScore W3120814732C70410870 @default.
• W3120814732 hasConceptScore W3120814732C71924100 @default.
• W3120814732 hasConceptScore W3120814732C98274493 @default.
• W3120814732 hasIssue "13" @default.
• W3120814732 hasLocation W31208147321 @default.
• W3120814732 hasOpenAccess W3120814732 @default.
• W3120814732 hasPrimaryLocation W31208147321 @default.
• W3120814732 hasRelatedWork W1899508519 @default.
• W3120814732 hasRelatedWork W2264325847 @default.
• W3120814732 hasRelatedWork W2351940698 @default.
• W3120814732 hasRelatedWork W2366572806 @default.
• W3120814732 hasRelatedWork W2382031461 @default.
• W3120814732 hasRelatedWork W2386886035 @default.
• W3120814732 hasRelatedWork W2897828366 @default.
• W3120814732 hasRelatedWork W2903717770 @default.
• W3120814732 hasRelatedWork W3141338185 @default.
• W3120814732 hasRelatedWork W4313574344 @default.
• W3120814732 isParatext "false" @default.
• W3120814732 isRetracted "false" @default.
• W3120814732 magId "3120814732" @default.
• W3120814732 workType "article" @default.